Trending Tickers: ARCA biopharma, Inc. (NASDAQ:ABIO), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), McKesson Corporation (NYSE:MCK), Biogen Inc. (NASDAQ:BIIB), Bank of America Corporation (NYSE:BAC)

ARCA biopharma, Inc. (NASDAQ:ABIO) belongs to Healthcare sector. Its weekly performance is 12.38%. On last trading day company shares ended up $1.09. ARCA biopharma, Inc. (NASDAQ:ABIO) distance from 50-day simple moving average (SMA50) is 24.97%. ARCA biopharma, Inc. (NASDAQ:ABIO) announced the closing of the previously announced private placement financing with a select group of institutional investors, including lead investor Venrock, New Enterprise Associates (NEA), funds managed by Franklin Advisers, Inc., RA Capital Management, Tekla Life Sciences Investors and other institutional investors. ARCA received net proceeds of approximately $34 million from the sale of approximately 42 million units at a price of$0.8805 per unit. Each unit consists of one share of ARCA’s common stock and a warrant to purchase 0.40 shares of common stock with an exercise price of $0.8716.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares fell -0.67% in last trading session and ended the day at $4.44. ARNA Gross Margin is 76.40% and its return on assets is -18.80%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) quarterly performance is -0.45%. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced today that Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer, has decided to leave the company after nearly 18 years of service to pursue another opportunity in the biotechnology industry. Mr. Hoffman is expected to remain in his current role at Arena until July 10, 2015.

On 02 July, McKesson Corporation (NYSE:MCK) shares fell -0.67% and was closed at $224.26. MCK EPS growth in last 5 year was 10.30%. McKesson Corporation (NYSE:MCK) year to date (YTD) performance is 8.26%. McKesson Corporation (NYSE:MCK) reaffirmed its earnings guidance for the fiscal year ending March 31, 2016 and the underlying key assumptions provided in its press release of May 12, 2015.

Biogen Inc. (NASDAQ:BIIB) belongs to Healthcare sector. Its net profit margin is 32.40% and weekly performance is -1.70%. On last trading day company shares ended up $404.28. Biogen Inc. (NASDAQ:BIIB) distance from 50-day simple moving average (SMA50) is 2.18%. Biogen Inc. (NASDAQ:BIIB) and Swedish Orphan Biovitrum announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) of ALPROLIX® (rFIXFc), a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. This validation signifies the initiation of the EMA’s review process.

Bank of America Corporation (NYSE:BAC) belongs to Financial sector. Its net profit margin is 14.70% and weekly performance is -1.96%. On last trading day company shares ended up $17.03. Bank of America Corporation (NYSE:BAC) distance from 50-day simple moving average (SMA50) is 1.92%. It was announced on June 30 that Energy banker Chris Getz is joining JPMorgan Chase & Co. from Bank of America Corp., where he has worked for about five years.

Leave a Reply

Your email address will not be published. Required fields are marked *